ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0430

Examining the Validity of a Subjective Urine Questionnaire for Residual Kidney Function Among Recruited Participants of the Incremental Hemodialysis in Veterans (INCHVETS) Randomized Controlled Trial

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Kalantar-Zadeh, Kamyar, VA Long Beach Healthcare System, Long Beach, California, United States
  • Kovesdy, Csaba P., VA Memphis Healthcare System, Memphis, Tennessee, United States
  • Unruh, Mark L., New Mexico VA Health Care System, Albuquerque, New Mexico, United States
  • Kraut, Jeffrey A., VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Geller, David, VA Connecticut Healthcare System West Haven VA Medical Center, West Haven, Connecticut, United States
  • Goldfarb, David S., VA New York Harbor Healthcare System, New York, New York, United States
  • Tran, Diana, VA Long Beach Healthcare System, Long Beach, California, United States
  • Rastegar, Mandana, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Rifkin, Ian R., VA Boston Healthcare System, West Roxbury, Massachusetts, United States
  • Schwartz, Gregory G., VA Eastern Colorado Health Care System, Aurora, Colorado, United States
  • Crowley, Susan T., VA Connecticut Healthcare System West Haven VA Medical Center, West Haven, Connecticut, United States
  • Rhee, Connie, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
Background

Higher residual renal function (RRF) in incident hemodialysis (HD) patients can support uremia management, so that less than thrice-weekly HD can be instituted. We hypothesized that urine volume (UV), a surrogate of RRF at the onset of HD transition, can be estimated using questionnaires.

Methods

We developed and tested the accuracy of a subjective UV in recruited human subjects of the INCHVETS trial, with several incremental responses to the question: “How much urine do you usually make a day?” 1) no more than 1 coffee mug. 2) 1 to 2 coffee mugs, 3) More than 2 coffee mugs but no more than 1 quart, and 5) more than a quart a day. We also asked: “Do you wake up at night to go to bathroom to pee?” with the answer options of Yes versus No/Not sure. We collected and measured 24 hour-output at baseline prior to randomization to twice vs thrice weekly HD in the first 8 weeks of dialysis initiation.

Results

In the first 109 recruited patients of the INCHVETS trial, the mean age is 70 (SD: ±9) years. They include 94% male, 51% Black Americans, and 23% Hispanics; and 67% has diabetes mellitus at dialysis initiation. Measured UV (mUV) was incrementally higher across 5 subjectively reported (p-for-trend <0.05, see Table 1), but reported nocturia was not significantly different: Yes (87%): 1,227±532 ml/day, No/not sure (13%) 1,105±592 ml/day.

Conclusion

In the first 109 INCHVETS trial patients, patients’ subjective estimates of their urine shows a positive trend with measured 24-hour urine output, while reported nocturia exhibited no association with reported or measured urine output. Given the requirement of at least 500 ml/day of urine to participate in the INCHVETS trial, we will compare the change in RRF over the 12 months of trials in patients who are randomized to twice- vs thrice-weekly HD.

Funding

  • Veterans Affairs Support

Digital Object Identifier (DOI)